Search Results
Search for other papers by Thomas M Braxton in
Google Scholar
PubMed
Search for other papers by Dionne E A Sarpong in
Google Scholar
PubMed
Search for other papers by Janine L Dovey in
Google Scholar
PubMed
Search for other papers by Anne Guillou in
Google Scholar
PubMed
Search for other papers by Bronwen A J Evans in
Google Scholar
PubMed
Search for other papers by Juan M Castellano in
Google Scholar
PubMed
Search for other papers by Bethany E Keenan in
Google Scholar
PubMed
Search for other papers by Saja Baraghithy in
Google Scholar
PubMed
Search for other papers by Sam L Evans in
Google Scholar
PubMed
CIBER Fisiopatologia de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain
Search for other papers by Manuel Tena-Sempere in
Google Scholar
PubMed
Search for other papers by Patrice Mollard in
Google Scholar
PubMed
Search for other papers by Joseph Tam in
Google Scholar
PubMed
Search for other papers by Timothy Wells in
Google Scholar
PubMed
Human Prader–Willi syndrome (PWS) is characterised by impairments of multiple systems including the growth hormone (GH) axis and skeletal growth. To address our lack of knowledge of the influence of PWS on skeletal integrity in mice, we have characterised the endocrine and skeletal phenotype of the PWS-IC del mouse model for ‘full’ PWS and determined the impact of thermoneutrality. Tibial length, epiphyseal plate width and marrow adiposity were reduced by 6, 18 and 79% in male PWS-IC del mice, with osteoclast density being unaffected. Similar reductions in femoral length accompanied a 32% reduction in mid-diaphyseal cortical diameter. Distal femoral Tb.N was reduced by 62%, with individual trabeculae being less plate-like and the lattice being more fragmented (Tb.Pf increased by 63%). Cortical strength (ultimate moment) was reduced by 26% as a result of reductions in calcified tissue strength and the geometric contribution. GH and prolactin contents in PWS-IC del pituitaries were reduced in proportion to their smaller pituitary size, with circulating IGF-1 concentration reduced by 37–47%. Conversely, while pituitary luteinising hormone content was halved, circulating gonadotropin concentrations were unaffected. Although longitudinal growth, marrow adiposity and femoral geometry were unaffected by thermoneutrality, strengthened calcified tissue reversed the weakened cortex of PWS-IC del femora. While underactivity of the GH axis may be due to loss of Snord116 expression and impaired limb bone geometry and strength due to loss of Magel2 expression, comprehensive analysis of skeletal integrity in the single gene deletion models is required. Our data imply that thermoneutrality may ameliorate the elevated fracture risk associated with PWS.
Search for other papers by R. V. BROOKS in
Google Scholar
PubMed
Search for other papers by B. S. HETZEL in
Google Scholar
PubMed
Search for other papers by R. R. McSWINEY in
Google Scholar
PubMed
Search for other papers by F. T. G. PRUNTY in
Google Scholar
PubMed
SUMMARY
Changes in response of the adrenal cortex to corticotrophin caused by the simultaneous intravenous administration of tri-iodothyronine have been studied in two patients with anterior pituitary insufficiency.
Tri-iodothyronine caused increases in urinary excretion of ketogenic steroids and in plasma hydrocortisone. Blood eosinophils fell sharply. In addition, changes in sodium and potassium balance, and fasting blood sugar levels were observed which were consistent with increased activity of the adrenal cortex. Rapid changes in b.m.r., serum creatine and blood cholesterol were those known to be produced by tri-iodothyronine alone; so, to a large extent, was the increased negative nitrogen balance.
Search for other papers by P. CUSHMAN Jr. in
Google Scholar
PubMed
Search for other papers by J. G. HILTON in
Google Scholar
PubMed
SUMMARY
Intravenous 8 hr. metyrapone tests were performed in 12 patients with probable pituitary tumours. Plasma 17-hydroxycorticosteroids and substance S concentrations were measured, and the concentrations of 11-deoxycortisol present after 8 hr. of continuous metyrapone administration were employed as the quantitative criterion of responsiveness. Plasma 11-deoxycortisol, undetectable at the start, rose at 8 hr. to 10·1 ± 1·5 s.e. (range 6–14) μg./100 ml. in the 15 normal control subjects. Three patterns of pituitary adrenal function were seen in the patients. Group I (three cases) had secondary adrenal insufficiency. A second group (five cases) was normal by all tests. The third group of patients (four cases) had normal baseline plasma and urinary corticosteroids but was distinguished from the normal subjects by subnormal 11-deoxycortisol levels after metyrapone. Two subjects had also subnormal responses to corticotrophin (ACTH), indicating partial secondary hypoadrenalism. In the two others whose response to ACTH stimulation was normal, impairment of ACTH release would not have been suspected without the metyrapone test. It is in the detection of this type of patient with occult pituitary insufficiency that tests with metyrapone may be of great value.
Search for other papers by John A H Wass in
Google Scholar
PubMed
Search for other papers by Raghava Reddy in
Google Scholar
PubMed
any specific grant from any funding agency in the public, commercial or not-for-profit sector. References Burman P Deijen JB 1998 Quality of life and cognitive function in patients with pituitary insufficiency . Psychotherapy and
Search for other papers by Eun Jig Lee in
Google Scholar
PubMed
Search for other papers by J Larry Jameson in
Google Scholar
PubMed
means to reduce the immune responsiveness to adenoviruses. Gene therapy strategies for treating pituitary insufficiency Vector considerations for long-term hormone replacement Long-term expression of a
Search for other papers by E Nieves-Martinez in
Google Scholar
PubMed
Search for other papers by W E Sonntag in
Google Scholar
PubMed
Search for other papers by A Wilson in
Google Scholar
PubMed
Search for other papers by A Donahue in
Google Scholar
PubMed
Search for other papers by D P Molina in
Google Scholar
PubMed
Neuroscience Program, Physiology and Pharmacology, Department of Internal Medicine, Reynolds Oklahoma Center on Aging, Neurobiology and Anatomy
Search for other papers by J Brunso-Bechtold in
Google Scholar
PubMed
Neuroscience Program, Physiology and Pharmacology, Department of Internal Medicine, Reynolds Oklahoma Center on Aging, Neurobiology and Anatomy
Neuroscience Program, Physiology and Pharmacology, Department of Internal Medicine, Reynolds Oklahoma Center on Aging, Neurobiology and Anatomy
Search for other papers by M M Nicolle in
Google Scholar
PubMed
JJ Laron Z 1968 Psychological aspects of pituitary insufficiency in children and adolescents with special reference to growth hormone . Israel Journal of Medical Sciences 4 953 – 961 . Galatzer A Aran O Nagelberg N Rubitzek J Laron
Search for other papers by Marion Walser in
Google Scholar
PubMed
Laboratory of Experimental Endocrinology, Endocrinology, Department of Clinical Chemistry and Transfusion Medicine, Institute of Neuroscience and Physiology, Department of Primary Health Care, AstraZeneca Research and Development, Clinical Neurochemistry Laboratory, InnoExt AB, Department of Internal Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gröna Stråket 8, SE-41345 Göteborg, Sweden
Search for other papers by Maria Teresa Samà in
Google Scholar
PubMed
Search for other papers by Ruth Wickelgren in
Google Scholar
PubMed
Laboratory of Experimental Endocrinology, Endocrinology, Department of Clinical Chemistry and Transfusion Medicine, Institute of Neuroscience and Physiology, Department of Primary Health Care, AstraZeneca Research and Development, Clinical Neurochemistry Laboratory, InnoExt AB, Department of Internal Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gröna Stråket 8, SE-41345 Göteborg, Sweden
Search for other papers by Maria Åberg in
Google Scholar
PubMed
Search for other papers by Mohammad Bohlooly-Y in
Google Scholar
PubMed
Search for other papers by Bob Olsson in
Google Scholar
PubMed
Search for other papers by Jan Törnell in
Google Scholar
PubMed
Search for other papers by Jörgen Isgaard in
Google Scholar
PubMed
Laboratory of Experimental Endocrinology, Endocrinology, Department of Clinical Chemistry and Transfusion Medicine, Institute of Neuroscience and Physiology, Department of Primary Health Care, AstraZeneca Research and Development, Clinical Neurochemistry Laboratory, InnoExt AB, Department of Internal Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gröna Stråket 8, SE-41345 Göteborg, Sweden
Search for other papers by N David Åberg in
Google Scholar
PubMed
Characterization of a neuronal subtype of insulin-like growth factor I receptor . Journal of Biological Chemistry 262 1618 – 1622 . Burman P Deijen JB 1998 Quality of life and cognitive function in patients with pituitary insufficiency . Psychotherapy
Search for other papers by Han Yan in
Google Scholar
PubMed
Search for other papers by Matthew Mitschelen in
Google Scholar
PubMed
Search for other papers by Georgina V Bixler in
Google Scholar
PubMed
Search for other papers by Robert M Brucklacher in
Google Scholar
PubMed
Search for other papers by Julie A Farley in
Google Scholar
PubMed
Search for other papers by Song Han in
Google Scholar
PubMed
Search for other papers by Willard M Freeman in
Google Scholar
PubMed
Search for other papers by William E Sonntag in
Google Scholar
PubMed
Genomics 1 26 doi:10.1186/1755-8794-1-26 . Burman P Deijen JB 1998 Quality of life and cognitive function in patients with pituitary insufficiency . Psychotherapy and Psychosomatics 67 154 – 167 . doi:10.1159/000012276 . Burman P Broman
Department of Pediatrics, Department of Endocrinology, Centro de Investigación Biomédica en Red de fisiopatología de la obesidad y nutrición (CIBERobn), Universidad Autónoma de Madrid, Madrid, Spain
Search for other papers by Eva Baquedano in
Google Scholar
PubMed
Department of Pediatrics, Department of Endocrinology, Centro de Investigación Biomédica en Red de fisiopatología de la obesidad y nutrición (CIBERobn), Universidad Autónoma de Madrid, Madrid, Spain
Search for other papers by Julie A Chowen in
Google Scholar
PubMed
Department of Pediatrics, Department of Endocrinology, Centro de Investigación Biomédica en Red de fisiopatología de la obesidad y nutrición (CIBERobn), Universidad Autónoma de Madrid, Madrid, Spain
Department of Pediatrics, Department of Endocrinology, Centro de Investigación Biomédica en Red de fisiopatología de la obesidad y nutrición (CIBERobn), Universidad Autónoma de Madrid, Madrid, Spain
Search for other papers by Jesús Argente in
Google Scholar
PubMed
Department of Pediatrics, Department of Endocrinology, Centro de Investigación Biomédica en Red de fisiopatología de la obesidad y nutrición (CIBERobn), Universidad Autónoma de Madrid, Madrid, Spain
Search for other papers by Laura M Frago in
Google Scholar
PubMed
. International Journal of Biochemistry & Cell Biology 40 1984 – 1989 . ( doi:10.1016/j.biocel.2007.07.008 ) Burman P Deijen J 1998 Quality of life and cognitive function in patients with pituitary insufficiency . Psychotherapy
Search for other papers by Alfhild Grönbladh in
Google Scholar
PubMed
Search for other papers by Jenny Johansson in
Google Scholar
PubMed
Search for other papers by Anatole Nöstl in
Google Scholar
PubMed
Search for other papers by Fred Nyberg in
Google Scholar
PubMed
Search for other papers by Mathias Hallberg in
Google Scholar
PubMed
.1055/s-2007-965808 ) Burman P Deijen JB 1998 Quality of life and cognitive function in patients with pituitary insufficiency . Psychotherapy and Psychosomatics 67 154 – 167 . ( doi:10.1159/000012276 ) Burman P Broman JE Hetta J Wiklund